Praveen P. Tipirneni - Jan 14, 2022 Form 4 Insider Report for Morphic Holding, Inc. (MORF)

Role: President and CEO, Director
Signature: /s/ Robert Farrell as attorney-in-fact for Praveen P. Tipirneni
Stock symbol: MORF
Transactions as of: Jan 14, 2022
Transactions value $: $0
Form type: 4
Date filed: 1/19/2022, 06:14 PM
Next filing: Jan 18, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	MORF	Common Stock						4.21K	Jan 14, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MORF	Stock Option (right to buy Common Stock)	Award	$0	+224K		$0.00	224K	Jan 14, 2022	Common Stock	224K	$44.75	Direct	F2
transaction	MORF	Restricted Stock Units (RSU)	Award	$0	+50K		$0.00	50K	Jan 14, 2022	Common Stock	50K		Direct	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 920 shares of Common Stock acquired under the issuer's employee stock purchase plan on February 26, 2021.
F2	The option vests as to 2.0833% of the total shares monthly, beginning February 14, 2022, with 100% of the total shares vested and exercisable on January 14, 2026, subject to the reporting person's provision of service to the issuer on each vesting date.
F3	Each RSU represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.
F4	The RSUs vest as to 25% of the total shares on each of January 14, 2023, January 14, 2024, January 14, 2025, and January 14, 2026, subject to the reporting person's provision of service to the issuer on each vesting date.